🇪🇺 Sitravatinib in European Union

Sitravatinib (sitravatinib) regulatory status in European Union.

Marketing authorisation

EMA

  • Status: approved

Sitravatinib in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in European Union

Frequently asked questions

Is Sitravatinib approved in European Union?

Yes. EMA has authorised it.

Who is the marketing authorisation holder for Sitravatinib in European Union?

Pfizer is the originator. The local marketing authorisation holder may differ — check the official source linked above.